Clinical characteristics of 512 eculizumab-naive paroxysmal nocturnal hemoglobinuria patients in China: a single-center observational study

Bibliographic Details
Title: Clinical characteristics of 512 eculizumab-naive paroxysmal nocturnal hemoglobinuria patients in China: a single-center observational study
Authors: Yali Du, Yuan Yang, Chen Yang, Miao Chen, Bing Han
Source: Hematology, Vol 27, Iss 1, Pp 113-121 (2022)
Publisher Information: Taylor & Francis Group, 2022.
Publication Year: 2022
Collection: LCC:Diseases of the blood and blood-forming organs
Subject Terms: paroxysmal nocturnal hemoglobinuria, clinical manifestations, classic, bone marrow failure, complement inhibitors, Diseases of the blood and blood-forming organs, RC633-647.5
More Details: Objectives With large patient population and complement inhibitors naïve background, the characteristics patients with paroxysmal nocturnal hemoglobinuria (PNH) in China have not been well studied, especially for different subtypes. Methods We retrospectively reviewed patients with complete data who visited Peking Union Medical College Hospital (PUMCH) from 2009 to 2019 and had been followed up for more than 2 years. Results Five hundred and twelve patients were enrolled including 56.3% males and 43.7% females. The median age at disease onset was 33 (9∼80) years. Most were aged 21∼40 years (50.6%). 52.1%, 46.3% and 1.6% of the patients had classic PNH, bone marrow failure (BMF)/PNH and subclinical PNH, respectively. Symptoms of classic PNH were associated with hemolysis, whereas bleeding was more common in BMF/PNH patients. Classic PNH had higher survival rate, larger PNH clone size, higher lactate dehydrogenase (LDH) level and lower ferritin level than BMF/PNH. Although the rate of thrombosis was similar in the classic PNH and BMF/PNH (P = 0.66), those with BMF/PNH had higher chance of renal impairment (P
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1607-8454
16078454
Relation: https://doaj.org/toc/1607-8454
DOI: 10.1080/16078454.2021.2022849
Access URL: https://doaj.org/article/9f89bf4a455c46d8b54c4bbd597ba4c5
Accession Number: edsdoj.9f89bf4a455c46d8b54c4bbd597ba4c5
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:16078454
DOI:10.1080/16078454.2021.2022849
Published in:Hematology
Language:English